IL10 and breast cancer: While we could observe the prominent difference between BC patients and healthy donors in IL-10-induced pSTAT3 in a per-measurement analysis without the aid of CPD (Fig. 2i), we wondered whether the CPD results offer additional insight into this prominent difference.